Understanding clinical risk decision making regarding development of depression during interferon-alpha treatment for hepatitis-C: A qualitative interview study

Files in This Item:
File Description SizeFormat 
Hepgul_&_Kodate_et_al_2012.pdf491.3 kBAdobe PDFDownload
Title: Understanding clinical risk decision making regarding development of depression during interferon-alpha treatment for hepatitis-C: A qualitative interview study
Authors: Hepgul, Nilay
Kodate, Naonori
Anderson, Janet E.
et al.
Permanent link: http://hdl.handle.net/10197/4916
Date: Dec-2012
Abstract: Background: Hepatitis C virus (HCV) affects 170 million worldwide. Currently, around 30% of patients receiving interferon-alpha (IFN-α) treatment for HCV experience clinically significant depression. Effective and timely detection of depression is crucial to ensuring appropriate treatment and support. However, little is known about how clinical nurse specialists identify patients at risk of developing interferon-alpha-induced depression, and monitor those receiving antiviral treatment for the occurrence of depression.
Type of material: Journal Article
Publisher: Elsevier
Copyright (published version): 2012 Elsevier Ltd.
Keywords: Decision-making;Depression;Hepatitis C;Interferon-alpha;Nurse Clinicians
DOI: 10.1016/j.ijnurstu.2012.07.016
Language: en
Status of Item: Peer reviewed
Appears in Collections:Social Policy, Social Work and Social Justice Research Collection

Show full item record

SCOPUSTM   
Citations 50

3
Last Week
0
Last month
checked on Jun 22, 2018

Page view(s) 50

80
checked on May 25, 2018

Download(s) 50

131
checked on May 25, 2018

Google ScholarTM

Check

Altmetric


This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.